INTENT Biologics
PrivateLast Round
VC Round
Sep 1, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
INTENT Biologics is a biotechnology company that develops exosome-based therapeutics for advanced wound care and immune-mediated conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
INTENT Biologics Comparables
Compare INTENT Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aegle Therapeutics Corp | 79% | |
| BREXOGEN Inc. | 69% | |
| Direct Biologics | 68% |
INTENT Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 1, 2025 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Monthly visitors increased 314% MoM.
INTENT Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about INTENT Biologics's valuation, stock price, and market status.
Is INTENT Biologics a public or private company?
INTENT Biologics is a private company.
What is the current stock price of INTENT Biologics?
INTENT Biologics is a private company with no public stock price. No recent secondary market data is available.
How much is INTENT Biologics worth (valuation)?
Valuation information for INTENT Biologics is not publicly available.
Can I buy INTENT Biologics stock?
INTENT Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was INTENT Biologics's last funding round?
INTENT Biologics's most recent funding round was VC Round on September 1, 2025.
Who are the main investors in INTENT Biologics?
Investor information for INTENT Biologics is not publicly disclosed.
Will INTENT Biologics IPO soon?
No public IPO plans have been announced for INTENT Biologics.
How can I track INTENT Biologics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor INTENT Biologics's secondary market activity and sign up for updates.